Home Applications 217906 Application 217906
Type NDA
Sponsor ABBVIE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 EMBLAVEO AVIBACTAM SODIUM; AZTREONAM POWDER;INTRAVENOUS EQ 0.5GM BASE/VIAL;1.5GM/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217906-001 EMBLAVEO AVIBACTAM SODIUM; AZTREONAM EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217906-001 NP 2028-02-07 N217906-001 GAIN 2033-02-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217906-001 NP 2028-02-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 GAIN 2033-02-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 NP 2028-02-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 GAIN 2033-02-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217906-001 NP 2028-02-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 GAIN 2033-02-07 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 NP 2028-02-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 GAIN 2033-02-07 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join EMBLAVEO AZTREONAM AND AVIBACTAM AbbVie Inc. be1a6c99-d4b3-46d7-9e99-6e5f9fab556a 2026-06-04 Warnings, Adverse reactions Exact identifier application applno (NDA): 217906 application number: NDA217906
Documents# Document, Submission type, Date table Document Submission type Date 85320 ORIG 2026-03-10 81182 ORIG 2025-02-10 81125 ORIG 2025-02-07